These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 34228240)

  • 1. Percutaneous cryoablation of 100 anterior renal tumors: safety and technical success.
    Raja J; Pigg R; Li Y; Savage C; Caridi TM; Huang J; Gunn AJ
    Abdom Radiol (NY); 2024 Mar; 49(3):919-926. PubMed ID: 38150142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Technical Feasibility of Percutaneous Renal Cryoablation of Central Tumors without Pyeloperfusion.
    Pigg RA; Raja JY; Babar T; Li Y; Li M; Huang J; Gunn AJ
    J Vasc Interv Radiol; 2024 Apr; 35(4):533-540. PubMed ID: 38219902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipiodol marking before CT-guided cryoablation on the outcome of sporadic renal cell carcinoma.
    Ushijima Y; Okamoto D; Fujita N; Ishimatsu K; Wada N; Takao S; Murayama R; Itoyama M; Ishigami K
    Diagn Interv Radiol; 2024 Mar; 30(2):117-123. PubMed ID: 38164892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Tyrosine Kinase Inhibitors Before Percutaneous Cryoablation for Clinical T1b Renal Tumors.
    Iwatani K; Kimura S; Urabe F; Matsukawa A; Aikawa K; Yanagisawa T; Shimizu K; Miki K; Kimura T; Miki J
    Cureus; 2024 May; 16(5):e60345. PubMed ID: 38883051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryoablation following neoadjuvant tyrosine kinase inhibitor as treatment of a T1a renal clear cell carcinoma in a patient with a solitary kidney.
    Diederichsen MZ; Weile KS; Christiansen CB; Pietersen PI
    BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37567735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Renal Tumor Cryoablation Effect on Renal Function.
    Knudsen JS; Duus LA; Junker T; Mussmann B; Graumann O
    J Endourol; 2023 Oct; 37(10):1149-1155. PubMed ID: 37578120
    [No Abstract]   [Full Text] [Related]  

  • 7. External validation of the ability of the mRENAL nephrometry score to identify patients at risk for major adverse events or local tumor recurrence after percutaneous renal cryoablation.
    Allen DM; Babar T; GloryAkinduro O; Li M; Khudari HE; Gunn AJ
    Abdom Radiol (NY); 2024 Aug; ():. PubMed ID: 39150544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Percutaneous Cryoablation on Renal Function in Patients with Stage I Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Chlorogiannis DD; Chlorogiannis A; Filippiadis DK; Kelekis A; Makris GC; Georgiades C
    J Vasc Interv Radiol; 2024 Sep; 35(9):1278-1287.e3. PubMed ID: 38914159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptance and results of cryoablation for the treatment of early breast cancer in non-surgical patients.
    Graña-López LL; Abelairas-López LL; Fernández-Sobrado II; Verea-Varela SS; Villares-Armas ÁA
    Br J Radiol; 2024 Oct; 97(1162):1713-1723. PubMed ID: 39073890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same-day discharge after percutaneous renal cryoablation and its effect on 30 day hospital re-admission rates and post-procedural complications.
    Akinduro OG; Babar T; Allen DM; Li M; Salei A; Huang J; Gunn AJ
    Curr Probl Diagn Radiol; 2024; 53(6):689-694. PubMed ID: 38735794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoprobe Placement Using Electromagnetic Navigation System (IMACTIS® CT-Navigation™) for Cryoablation Treatment of Upper Kidney Pole Lesions and Adrenal Metastases: Experience from a Single-Center, 4-Year Study.
    Michailidis A; Kosmoliaptsis P; Dimou G; Mingou G; Zlika S; Giankoulof C; Galanis S; Petsatodis E
    Diagnostics (Basel); 2024 Sep; 14(17):. PubMed ID: 39272747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview.
    Knight A; Gunn AJ
    Curr Oncol Rep; 2024 Jul; 26(7):754-761. PubMed ID: 38767829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Focal Therapy and Active Surveillance for Small Renal Mass Therapy.
    Matuszczak M; Kiljańczyk A; Salagierski M
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image-guided percutaneous cryoablation of T1b renal cell carcinomas in patients with comorbidities.
    Shimizu K; Enoki K; Kameoka Y; Motohashi K; Yanagisawa T; Miki J; Baba A; Sekiguchi H; Sadaoka S
    Jpn J Radiol; 2021 Dec; 39(12):1213-1222. PubMed ID: 34228240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial embolization of T1b and T2a renal cell carcinoma prior to percutaneous cryoablation: a retrospective comparative study.
    Salei A; Raymond M; Savage C; Huang J; Caridi TM; Rais-Bahrami S; Gunn AJ
    Abdom Radiol (NY); 2023 Feb; 48(2):773-779. PubMed ID: 36454278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of CT-guided percutaneous cryoablation of T1a and T1b renal cell carcinoma.
    Spiliopoulos S; Marzoug A; Ra H; Arcot Ragupathy SK
    Diagn Interv Radiol; 2021 Jul; 27(4):524-528. PubMed ID: 34313238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Image-Guided Cryoablation of Endophytic Renal Cell Carcinoma.
    Jensen CG; Dybdahl M; Valtersson J; Mussmann BR; Duus LA; Junker T; Pietersen PI; Lund L; Welch BT; Graumann O
    Cardiovasc Intervent Radiol; 2024 Apr; 47(4):453-461. PubMed ID: 38483602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoablation of small kidney tumors.
    Zondervan PJ; Buijs M; de la Rosette JJ; van Delden O; van Lienden K; Laguna MP
    Int J Surg; 2016 Dec; 36(Pt C):533-540. PubMed ID: 27500963
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.